COVID?=?coronavirus disease; MS?=?multiple sclerosis; OCR?=?ocrelizumab
COVID?=?coronavirus disease; MS?=?multiple sclerosis; OCR?=?ocrelizumab. Click here for additional data file.(16K, docx) Acknowledgments This work was supported by an unrestricted investigator\initiated grant from Genentech. and humoral immunity to severe acute respiratory syndrome\coronavirus Boc-D-FMK 2 (SARS\CoV\2) infection. Methods Patients with MS aged 18 to 60?years were evaluated for anti\nucleocapsid and anti\Spike receptor\binding domain (RBD) antibody with…